Staar Surgical Co.
STAA
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.21B
Close$
$2.17
91.5% downside
Current Fair Value
91.5% downsideOvervalued by 91.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.21 Billion |
|---|---|
| Enterprise Value | $1.14 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.62 |
| Beta | 1.23 |
| Outstanding Shares | 49,908,000 |
Return
| Return on Equity | -2253.23% |
|---|---|
| Return on Assets | -1759.98% |
| Return on Invested Capital | -1.87% |
Valuation & Multiples
| P/E Ratio | -57.64 |
|---|---|
| PEG | 52.59 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 3.63 |
| Enterprise Value to Revenue | 0.01 |
| Enterprise Value to EBIT | -156.16 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$0.22
Average shareholder expectationRevenue Estimate
$90.60 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.8683▼ 27.61% |
|---|---|
| Total Calls | 44,800▼ 89.43% |
| Total Puts | 38,900▼ 91.98% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 26.57%▼ 82.19% |
|---|---|
| Total Invested | $379.82M▼ 62.33% |
| Investors Holding | 70▼ 126.00% |
ESG Score
No data
About Staar Surgical Co.
CEO: Caren Mason